FDA Inspection 1054441 — Reproductive Medicine Institute

Reproductive Medicine Institute — FEI 3009383018

The FDA completed an inspection of Reproductive Medicine Institute on May 8, 2018 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 8, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chicago, IL (United States)